‘Vein-on-a-chip’ could help scientists study blood clots without animal models
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies.
The vein-on-a-chip model has been developed by scientists at BHP…
Drug combination could overcome tumour resistance in paediatric cancers
Children with some solid tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at the American Association of Cancer Research’s Ann…
West Midlands Innovation Accelerator to Spark Growth and Innovation
The Universities of Birmingham and Aston – both BHP members – are to participate in the West Midlands Innovation Accelerator announced this week by the West Midlands Combined Authority.Designed to …
Learning from the pandemic: Birmingham Health Partners publishes rapid evaluation study of remote outpatient appointments
Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has called for greater engagement with clinicians and a deeper understanding of patient experience when considering t…
New drug can lower brain pressure and treat blinding IIH headaches, finds trial
Patients with Idiopathic Intercranial Hypertension (IIH) – a condition which causes raised brain pressure and debilitating headaches – could be treated with an injectable peptide used for type 2 di…
Funding boost for Birmingham rare disease research
BHP founder-member the University of Birmingham has been awarded a £500k Pathfinder Award from the medical research charity LifeArc which will support early-stage projects with a focus on translati…